crypto vs digital currency Top Reviews

Tschudin, member of the management Committee of the Swiss National Bank: Due to the monetary easing policy, Swiss economic growth is expected to pick up slightly next year. Overseas developments are the main risks facing the Swiss economy.Weilai Li Bin: R&D investment is in basic research. Weilai's R&D expenses for Le Dao are far less than Xiaomi's R&D expenses for Xiaomi Automobile. (Sina Technology)The Polish minister said that Poland hopes that more countries will participate in Baltic policing, the EU must spend at least 100 billion euros on national defense, and the conditions for sending Polish MIG -29 fighters to Ukraine have not been met.

The Japanese yen faces new risks. Strategists worry that the Bank of Japan may wait until March or later to raise interest rates. A new risk is emerging for the Japanese yen. Foreign exchange strategists in Tokyo warn that the Bank of Japan may wait until March or later next year to raise interest rates. On Wednesday, the market tasted this danger, and the yen fell to its lowest level in more than two weeks as traders responded to a Bloomberg report that the Bank of Japan is known to think that it is no harm to raise interest rates later. The yen only fell to 152.82 against the dollar, and the market is still debating whether the Bank of Japan will take action at its next meeting on December 19 or about a month later. Shusuke Yamada, head of Japan's foreign exchange and interest rate strategy at Bank of America in Tokyo, said that if policymakers put off raising interest rates for a longer time, the situation would be very different. "If the interest rate hike is postponed until March, the yen carry trade is likely to make a comeback," Yamada said on Thursday. "The yen is likely to fall again to a level just below the 157 mark hit in 155 or November."Ai Kelan: The actual controller intends to transfer 5% shares of the company by agreement. Ai Kelan announced that Liu Yi, the controlling shareholder and actual controller of the company, intends to transfer 4 million unrestricted shares of the company to Guangdong Nanchuan Private Equity Fund Management Co., Ltd. by agreement transfer, accounting for 5.00% of the company's total share capital. If the transaction is finally completed, Liu Yi holds 33.89% of the company's shares, and Nanchuan Private Equity holds 5.00% of the company's shares. This change in equity will not lead to changes in the controlling shareholder and actual controller of the company. The transfer of shares in this agreement can only be handled in Shenzhen Branch of China Securities Depository and Clearing Co., Ltd. after the compliance confirmation of Shenzhen Stock Exchange. The share transfer price of this transaction is 20.61 yuan/share.People's Insurance Company of China: In the first November, the original insurance premium income of the three subsidiaries totaled 646.933 billion yuan. From January 1, 2024 to November 30, 2024, the original insurance premium income obtained through the subsidiaries of China People's Property Insurance Co., Ltd., China People's Life Insurance Co., Ltd. and China People's Health Insurance Co., Ltd. was 496.845 billion yuan, 102.591 billion yuan and 47.497 billion yuan respectively.

Mengke Pharmaceutical Co., Ltd.: The new packaging of Contizontamide tablets will be on the market soon. Mengke Pharmaceutical Co., Ltd. announced that the company has launched Contizontamide tablets with new packaging specifications, and a box of 12 tablets will be on the market soon. Contizontamide tablet is a new class 1 oxazolidinone antibacterial drug with global intellectual property rights. It was approved by National Medical Products Administration, China on June 1st, 2021 for the treatment of complex skin and soft tissue infections.The US media said that the Biden administration is considering imposing new sanctions on Russian oil trade. Informed sources: The details have yet to be finalized. The Bloomberg website reported on the 10th local time that the Biden administration is considering imposing new sanctions on Russian oil trade before Trump returns to the White House, and the specific details have yet to be finalized. The article said that the Biden administration is weighing new and stricter sanctions against Russia's lucrative oil trade, trying to increase pressure on the Kremlin before Trump returns to the White House. According to an insider who asked not to be named, the details of possible new measures are still being worked out, but Biden's team is considering imposing restrictions on some Russian oil exports. Up to now, the Russian side has not responded. (CCTV)Jichuan Pharmaceutical Co., Ltd. and Dongke Pharmaceutical Co., Ltd., a wholly-owned subsidiary, have recently received the Drug Registration Certificate for Children Faropenem Sodium Granules and Cefezoxime Sodium for Injection approved and issued by National Medical Products Administration.